Search

(F4) Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
(D4) Digesting the Disruption: Biosimilars, Benefits, and Barriers in IBD Care
(M4) Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics) and Biosimilars
(R4) Leveraging Mortality Data for Real-World Evidence in Managed Care: Challenges and Potential Solutions
(W4) Unlocking AI’s Potential in Managed Care: An Actionable Roadmap
Wednesday, 4/15 - Sessions from 2:45-4:00pm
(D5) Implementing a Comprehensive Asthma Care Management Program to Achieve Quality Improvement and Positive Health Outcomes
(F5) Diving into Data: An Introduction to Managed Care Research
(L5) From MFP to MFN — Price Controls, Politics & the Rebate Reckoning
(M5) Mind the Gap: Rethinking Oncology Management Before It’s Too Late
Wednesday, 4/15 - Sessions from 4:15-5:15pm
(D6) The Future of Metabolic Health in Managed Care: Population Risk and Financial Impact
(L6) State Legislative and Regulatory Update
(K2) Unpacking the Data: The Application and Interpretation of Real-World Evidence in GLP-1 Obesity Treatment
(K3) Emerging Specialty Pharmaceuticals: Current Development Landscape and Why It Matters
From Policy to Practice - PA/UM Trends, Evidence, and Coverage Alignment
A New Treatment Option for Adults With Obstructive Hypertrophic Cardiomyopathy (oHCM)
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
APFM Section 2 Module 6: CMS Final Rule on Patient Engagement in Managed Care Pharmacy: Putting Policy into Practice
The Evolving Anti-Obesity Medication Market: Payer Trends, Policy Shifts, and Access Strategies
Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
From MFP to MFN — Price Controls, Politics & the Rebate Reckoning

Pages